Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02637531 |
Title | A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IPI-549 |
Recruitment | Unknown status |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Infinity Pharmaceuticals, Inc. |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
UCSD | San Diego | California | 92093 | United States | Details | |
UCLA | Santa Monica | California | 90404 | United States | Details | |
Hematology Oncology Associates of the Treasure Coast | Port Saint Lucie | Florida | 34952 | United States | Details | |
Emory University | Atlanta | Georgia | 30322 | United States | Details | |
Massachusetts General Hospital | Boston | Massachusetts | 02116 | United States | Details | |
Beth Israel Deaconess Medical Center | Boston | Massachusetts | 02215 | United States | Details | |
Dana-Farber Cancer Institute | Boston | Massachusetts | 02215 | United States | Details | |
Hackensack University Medical Center | Hackensack | New Jersey | 07601 | United States | Details | |
Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | United States | Details | |
MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
South Texas Accelerated Research and Treatment (START) | San Antonio | Texas | 78229 | United States | Details |